₄Gilles Courtois

Summary for 2004 [at-glance overview of Gilles Courtois work for the selected year as suggested by data mining algorithms]

This is an Authoratory overview of author Gilles Courtois. According to available data, in 2004 Gilles Courtois published at least 4 articles. This work was completed in collaboration with several authors including Israël, Alain and Véron, Michel. Many other authors have collaborated with Gilles Courtois as well. There is no information about the funding or the grants awarded to support this work.

Gilles Courtois has rank 20 when compared to all other authors using the keyword I-kappa B Kinase. Analysis of the article abstracts and the titles suggests that Gilles Courtois professional interests are focused around "cc2 lz subdomains", "cc2 lz peptides" and "nf-kappa essential modulator". These might also be referred to as "cc2 lz", "ikk complex" or "nf-kappa activation". Statistical analysis shows that Gilles Courtois's writing is likely to contains terms "nemo", "activation", "nf-kappab", "nf-kappa", "lz" and "cc2".

Unfortunately, there is not enough information to establish Gilles Courtois affiliation. Luckily, one email address is on file.

EN FR ES RU

Inaccurate information, needs improvement

make correction leave comment ask question

Images [images we found on the Internet for Gilles Courtois]

Do you know Gilles Courtois who matches the profile above? Click the photo and let us know!

Alternative names (1) [other authors with names similar to Gilles Courtois]

₁₇Courtois, G

Year 2004 Charts [Gilles Courtois frequent coauthors and the most common unique vocabulary terms for the selected year]

Historical Performance Charts [graphical overview of Gilles Courtois publication and funding history for the range of years]

Emails (1) [email addresses extracted from Gilles Courtois affiliations]

hidden to prevent spam, click here to reveal

Gilles Courtois Coauthors (12) [all coauthors with the number of joint publications]

4

2

2

1

1

1

1

1

₃Ursini, Matilde Valeria

1

₂Coïc, Yves-Marie

1

₂Falco, Geppino

1

₁Fusco, Francesca

1

₁Miano, Maria Giuseppina

Other [context-specific ads]

Affiliations (4) [condensed summary of the Gilles Courtois affiliations, the leading number and the color conveys importance]

₁Unité de Régulation Enzymatique des Activités Cellulaires, CNRS URA 2185, 75724 Paris, France.
₁Institute of Genetics and Biophysics, Adriano Buzzati Traverso-CR, Naples, Italy.
₁Unité de Régulation Enzymatique des Activités Cellulaires, CNRS URA 2185, Institut Pasteur, 25 rue du Dr Roux, 75724 Paris Cedex 15, France.
₁Unité de Biologie Moléculaire de l'Expression Génique,URA 2582 CNRS, Institut Pasteur, 25, rue du Dr Roux, 75724 Paris Cedex 15, France.

Key Opinion Leader In [Gilles Courtois is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]

₂₀I-kappa B Kinase | ₁₄₃NF-kappa B | ₂₂₀Lipopolysaccharides | ₇₀₁Transfection

Keywords (32) [keywords assigned to Gilles Courtois articles by PubMed, the leading number and the color conveys importance]

₄NF-kappa B | ₃Mice | ₃Lipopolysaccharides | ₃Transfection | ₃Animals | ₃Humans | ₃I-kappa B Kinase | ₂Protein-Serine-Threonine Kinases | ₂Genetic Complementation Test | ₂Molecular Sequence Data | ₂Amino Acid Sequence | ₂Peptides | ₂Mutation | ₂Cell Line | ₁Mutagenesis, Site-Directed | ₁Mutagenesis | ₁Base Sequence | ₁Chromatography | ₁DNA-Binding Proteins | ₁Tumor Cells, Cultured | ₁Recombinant Fusion Proteins | ₁Recombinant Proteins | ₁Protein Structure, Secondary | ₁Protein Structure, Tertiary | ₁Carrier Proteins | ₁Gene Components | ₁Leucine Zippers | ₁Interleukin-2 | ₁Chromatography, Gel | ₁Drug Design | ₁Exons | ₁Pedigree

Gilles Courtois Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; Gilles Courtois might be a good expert witness on these terms]

₁₇nemo | ₁₄activation | ₁₂nf-kappab | ₁₂nf-kappa | ₁₁lz | ₁₁cc2 | ₁₀peptides | ₇subdomains | ₇complex | ₇oligomerization | ₇domain | ₆ikk | ₆role | ₆coiled-coil | ₅protein | ₅ikappab | ₄human | ₄pathologies | ₄modulator | ₄pathway | ₄c-terminal | ₄essential | ₄mutations | ₄gene | ₃molecular | ₃trimerization | ₃ip | ₃regulatory | ₃targeting | ₃inhibition | ₃family | ₃kinase
₉cc2 lz | ₆ikk complex | ₅nf-kappa activation | ₄oligomerization domain | ₄essential modulator | ₃lz subdomains | ₃lz peptides | ₃nf-kappab activation | ₃human pathologies | ₃nf-kappa essential | ₃coiled-coil subdomains | ₃inhibition nf-kappa | ₃domain nemo | ₂key role | ₂defect large | ₂lz coiled-coil | ₂targeting nf-kappa | ₂activation ikk | ₂c-terminal cc2 | ₂patients identification | ₂inhibitory molecules | ₂identification novel | ₂large cohort | ₂cohort ip | ₂plays key | ₂modulator nemo | ₂nf-kappa pathway | ₂interfering nf-kappab | ₂novel nemo | ₂nf-kappab pathway | ₂peptides targeting | ₂analysis genetic
₃cc2 lz subdomains | ₃cc2 lz peptides | ₃nf-kappa essential modulator | ₂inhibition nf-kappa activation | ₂isolated cc2 lz | ₂novel nemo mutations | ₂nf-kappa activation peptides | ₂plays key role | ₂molecular analysis genetic | ₂c-terminal cc2 lz | ₂peptides targeting nf-kappa | ₂identification novel nemo | ₂domain nemo composed | ₂activation peptides targeting | ₂trimerization domain nemo | ₂genetic defect large | ₂large cohort ip | ₂modulator nemo oligomerization | ₂nf-kappab activation human | ₂human pathologies associated | ₂mutations interfering nf-kappab | ₂patients identification novel | ₂cc2 lz coiled-coil | ₂pathologies associated nf-kappab | ₂associated nf-kappab defects | ₂analysis genetic defect | ₂targeting nf-kappa essential | ₂minimal oligomerization domain | ₂nemo composed interacting | ₂ip patients identification | ₂essential modulator nemo | ₂interfering nf-kappab activation

Reader's Comments (0) [comments posted by readers of Gilles Courtois profile]